Literature DB >> 2163022

Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system.

M R Tota1, M I Schimerlik.   

Abstract

The mechanism of action of the partial muscarinic agonist pilocarpine was analyzed in a reconstituted system consisting of the purified porcine atrial muscarinic receptor and the purified porcine atrial inhibitory guanine nucleotide-binding protein, Gi. When GTPase activity was measured as a function of receptor.agonist complex concentration at saturating concentrations of either the full agonist carbachol or pilocarpine, both ligands gave similar values of kcat (4.3 +/- 0.2 min-1 for carbachol and 5.4 +/- 0.7 min-1 for pilocarpine); however, the observed dissociation constant for the ligand.receptor complex binding to Gi was about 4-fold lower for carbachol (0.81 +/- 0.19 nM) than for pilocarpine (3.02 +/- 0.83 nM). These results suggested that, in this system, the reduced activity of the partial agonist compared with the full agonist was the result of a decrease in affinity of the receptor.ligand complex for Gi, as opposed to differences in their relative abilities to activate the guanine nucleotide-binding protein. Several analogues of oxotremorine were also tested to determine their effects on the GTPase activity of Gi. Results from these studies indicate that the reconstituted system may be useful in determining structure-function relationships for muscarinic agonists with regard to receptor.Gi interactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163022

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  4 in total

1.  Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.

Authors:  X P Huang; P I Nagy; F E Williams; S M Peseckis; W S Messer
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 2.  Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.

Authors:  N T Burford; J R Traynor; A Alt
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy.

Authors:  J Jakubík; H Janíčková; E E El-Fakahany; V Doležal
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

4.  RGS4 regulates partial agonism of the M2 muscarinic receptor-activated K+ currents.

Authors:  I-Shan Chen; Kazuharu Furutani; Atsushi Inanobe; Yoshihisa Kurachi
Journal:  J Physiol       Date:  2014-01-13       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.